PRTK Annual FCF
-$66.18 M
-$17.53 M-36.04%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual free cash flow is -$66.18 million, with the most recent change of -$17.53 million (-36.04%) on December 31, 2022. During the last 3 years, it has risen by +$68.11 million (+50.72%).PRTK Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly FCF
-$1.78 M
-$12.83 M-116.06%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly free cash flow is -$1.78 million, with the most recent change of -$12.83 million (-116.06%) on June 30, 2023. Over the past year, it has increased by +$12.72 million (+87.75%).PRTK Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK TTM FCF
-$23.25 M
+$12.72 M+35.37%
30 June 2023
Summary:
As of January 21, 2025, PRTK TTM free cash flow is -$23.25 million, with the most recent change of +$12.72 million (+35.37%) on June 30, 2023. Over the past year, it has increased by +$3.94 million (+14.48%).PRTK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.0% | +87.8% | +14.5% |
| 3 y3 years | +50.7% | +91.3% | +79.8% |
| 5 y5 years | +17.0% | +92.2% | +82.7% |
PRTK Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -556.4% | -103.9% | -163.1% |
Paratek Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$1.78 M(-116.1%) | -$23.25 M(-35.4%) |
| Mar 2023 | - | $11.06 M(-155.0%) | -$35.97 M(-45.6%) |
| Dec 2022 | -$66.18 M(+36.0%) | -$20.11 M(+62.0%) | -$66.18 M(+0.5%) |
| Sept 2022 | - | -$12.42 M(-14.3%) | -$65.87 M(+142.3%) |
| June 2022 | - | -$14.50 M(-24.3%) | -$27.19 M(-40.9%) |
| Mar 2022 | - | -$19.15 M(-3.3%) | -$46.01 M(-5.4%) |
| Dec 2021 | -$48.65 M(-53.1%) | -$19.81 M(-175.4%) | -$48.65 M(-7.8%) |
| Sept 2021 | - | $26.27 M(-178.8%) | -$52.73 M(-51.2%) |
| June 2021 | - | -$33.32 M(+53.0%) | -$107.96 M(+13.6%) |
| Mar 2021 | - | -$21.78 M(-8.9%) | -$95.00 M(-8.5%) |
| Dec 2020 | -$103.80 M(-22.7%) | -$23.89 M(-17.5%) | -$103.80 M(-10.2%) |
| Sept 2020 | - | -$28.96 M(+42.2%) | -$115.63 M(+0.7%) |
| June 2020 | - | -$20.37 M(-33.4%) | -$114.87 M(-11.0%) |
| Mar 2020 | - | -$30.58 M(-14.4%) | -$129.10 M(-3.9%) |
| Dec 2019 | -$134.28 M(+65.3%) | -$35.72 M(+26.7%) | -$134.28 M(+14.2%) |
| Sept 2019 | - | -$28.20 M(-18.5%) | -$117.55 M(+7.0%) |
| June 2019 | - | -$34.59 M(-3.3%) | -$109.82 M(+12.1%) |
| Mar 2019 | - | -$35.77 M(+88.3%) | -$97.93 M(+20.5%) |
| Dec 2018 | -$81.24 M(+1.9%) | -$18.99 M(-7.2%) | -$81.24 M(-4.0%) |
| Sept 2018 | - | -$20.47 M(-9.9%) | -$84.58 M(+6.2%) |
| June 2018 | - | -$22.70 M(+19.0%) | -$79.66 M(+9.2%) |
| Mar 2018 | - | -$19.08 M(-14.6%) | -$72.94 M(-8.5%) |
| Dec 2017 | -$79.69 M(-15.9%) | -$22.34 M(+43.7%) | -$79.69 M(-2.8%) |
| Sept 2017 | - | -$15.54 M(-2.8%) | -$81.96 M(-14.1%) |
| June 2017 | - | -$15.99 M(-38.1%) | -$95.41 M(-6.5%) |
| Mar 2017 | - | -$25.82 M(+4.9%) | -$102.00 M(+7.6%) |
| Dec 2016 | -$94.79 M(+70.7%) | -$24.61 M(-15.1%) | -$94.79 M(+10.2%) |
| Sept 2016 | - | -$28.99 M(+28.4%) | -$86.04 M(+8.8%) |
| June 2016 | - | -$22.58 M(+21.3%) | -$79.08 M(+11.8%) |
| Mar 2016 | - | -$18.61 M(+17.3%) | -$70.70 M(+27.3%) |
| Dec 2015 | -$55.54 M(+199.7%) | -$15.86 M(-28.0%) | -$55.54 M(+3.6%) |
| Sept 2015 | - | -$22.02 M(+55.0%) | -$53.61 M(+55.8%) |
| June 2015 | - | -$14.21 M(+312.5%) | -$34.40 M(+57.5%) |
| Mar 2015 | - | -$3.44 M(-75.3%) | -$21.85 M(+17.9%) |
| Dec 2014 | -$18.53 M | -$13.94 M(+395.1%) | -$18.53 M(+84.5%) |
| Sept 2014 | - | -$2.81 M(+70.6%) | -$10.04 M(+11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | -$1.65 M(+1159.5%) | -$9.05 M(-15.3%) |
| Mar 2014 | - | -$131.00 K(-97.6%) | -$10.68 M(-27.9%) |
| Dec 2013 | -$14.82 M(-2.8%) | -$5.45 M(+199.8%) | -$14.82 M(-35.3%) |
| Sept 2013 | - | -$1.82 M(-44.6%) | -$22.90 M(+56.8%) |
| June 2013 | - | -$3.28 M(-23.2%) | -$14.61 M(-8.5%) |
| Mar 2013 | - | -$4.27 M(-68.4%) | -$15.97 M(+4.7%) |
| Dec 2012 | -$15.25 M(+164.4%) | -$13.54 M(-308.9%) | -$15.25 M(-367.5%) |
| Sept 2012 | - | $6.48 M(-239.5%) | $5.70 M(-193.6%) |
| June 2012 | - | -$4.64 M(+30.8%) | -$6.09 M(+21.5%) |
| Mar 2012 | - | -$3.55 M(-147.9%) | -$5.01 M(-13.1%) |
| Dec 2011 | -$5.77 M(-70.6%) | $7.41 M(-239.6%) | -$5.77 M(-69.8%) |
| Sept 2011 | - | -$5.31 M(+49.0%) | -$19.08 M(+5.0%) |
| June 2011 | - | -$3.56 M(-17.2%) | -$18.17 M(-2.0%) |
| Mar 2011 | - | -$4.30 M(-27.1%) | -$18.55 M(-5.4%) |
| Dec 2010 | -$19.61 M(-3930.7%) | -$5.90 M(+34.1%) | -$19.61 M(+12.8%) |
| Sept 2010 | - | -$4.40 M(+11.8%) | -$17.39 M(-360.4%) |
| June 2010 | - | -$3.94 M(-26.7%) | $6.68 M(+101.6%) |
| Mar 2010 | - | -$5.37 M(+45.9%) | $3.31 M(+547.1%) |
| Dec 2009 | $512.00 K(-102.5%) | -$3.68 M(-118.7%) | $512.00 K(-104.6%) |
| Sept 2009 | - | $19.67 M(-369.2%) | -$11.18 M(-63.5%) |
| June 2009 | - | -$7.30 M(-10.6%) | -$30.60 M(-1.5%) |
| Mar 2009 | - | -$8.17 M(-46.8%) | -$31.08 M(+52.4%) |
| Dec 2008 | -$20.39 M(-240.6%) | -$15.37 M(-6425.5%) | -$20.39 M(+20.0%) |
| Sept 2008 | - | $243.00 K(-103.1%) | -$16.99 M(-160.3%) |
| June 2008 | - | -$7.79 M(-408.4%) | $28.18 M(-23.5%) |
| Mar 2008 | - | $2.52 M(-121.1%) | $36.84 M(+154.1%) |
| Dec 2007 | $14.50 M(-155.9%) | -$11.97 M(-126.4%) | $14.50 M(-27.4%) |
| Sept 2007 | - | $45.41 M(+5090.1%) | $19.97 M(-163.7%) |
| June 2007 | - | $875.00 K(-104.4%) | -$31.36 M(-18.3%) |
| Mar 2007 | - | -$19.82 M(+205.1%) | -$38.38 M(+48.0%) |
| Dec 2006 | -$25.93 M(+19.9%) | -$6.50 M(+9.7%) | -$25.93 M(+33.4%) |
| Sept 2006 | - | -$5.92 M(-3.7%) | -$19.43 M(+43.8%) |
| June 2006 | - | -$6.15 M(-16.6%) | -$13.51 M(+83.4%) |
| Mar 2006 | - | -$7.37 M | -$7.37 M |
| Dec 2005 | -$21.63 M(+25.5%) | - | - |
| Dec 2004 | -$17.23 M | - | - |
FAQ
- What is Paratek Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual FCF year-on-year change?
- What is Paratek Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly FCF year-on-year change?
- What is Paratek Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals TTM FCF year-on-year change?
What is Paratek Pharmaceuticals annual free cash flow?
The current annual FCF of PRTK is -$66.18 M
What is the all time high annual FCF for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual free cash flow is $14.50 M
What is Paratek Pharmaceuticals annual FCF year-on-year change?
Over the past year, PRTK annual free cash flow has changed by -$17.53 M (-36.04%)
What is Paratek Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of PRTK is -$1.78 M
What is the all time high quarterly FCF for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly free cash flow is $45.41 M
What is Paratek Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, PRTK quarterly free cash flow has changed by +$12.72 M (+87.75%)
What is Paratek Pharmaceuticals TTM free cash flow?
The current TTM FCF of PRTK is -$23.25 M
What is the all time high TTM FCF for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high TTM free cash flow is $36.84 M
What is Paratek Pharmaceuticals TTM FCF year-on-year change?
Over the past year, PRTK TTM free cash flow has changed by +$3.94 M (+14.48%)